Results 51 to 60 of about 3,030,087 (241)
Intrapancreatic accessory spleen false positive to 68Ga-Dotatoc: case report and literature review [PDF]
, 2019 Background: Intrapancreatic accessory spleen (IPAS) is an uncommon finding of pancreatic mass. Differential diagnosis with pancreatic tumor, especially with non-functional neuroendocrine tumor (NF-NET), may be very hard and sometimes it entails ...
Bellato, V. +9 more
core +1 more source
Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors
Nature Network Boston, 2019 Most pancreatic neuroendocrine tumors (PNETs) do not produce excess hormones and are therefore considered ‘non-functional’1–3. As clinical behaviors vary widely and distant metastases are eventually lethal2,4, biological classifications might guide ...
P. Cejas +26 more
semanticscholar +1 more source
Archives of Pathology & Laboratory Medicine, 2020 CONTEXT.— The 5th edition of the World Health Organization classification of digestive system tumors discusses several advancements and developments in understanding the etiology, pathogenesis, and diagnosis of several digestive tract tumors. OBJECTIVE.
N. Assarzadegan, E. Montgomery
semanticscholar +1 more source
Advanced ScienceO6‐methylguanine DNA methyltransferase (MGMT) removes alkyl adducts from the guanine O6 position (O6‐MG) and repairs DNA damage. High MGMT expression results in poor response to temozolomide (TMZ).
Junfeng Xu +16 more
doaj +1 more source
Updates and management algorithm for neuroendocrine tumors of the uterine cervix
International Journal of Gynecological Cancer, 2019 Neuroendocrine carcinomas of the cervix account for less than 2% of all invasive cervical cancers and are classified as low-grade (carcinoid, atypical carcinoid tumor) or high-grade (known as small- and large-cell) neuroendocrine carcinomas.
G. Salvo +3 more
semanticscholar +1 more source
Diagnostics, 2021 Grade 3 (G3) neuroendocrine tumors (NETs) are a novel category among digestive neuroendocrine neoplasms, characterized by Ki-67 >20% and a well-differentiated morphology, presenting high intra-tumor heterogeneity.
Alice Laffi +11 more
doaj +1 more source
Prediction of progression-free survival in patients with advanced, well-differentiated, neuroendocrine tumors being treated with a somatostatin analog: the GETNE-TRASGU study [PDF]
, 2019 Artículo escrito por un elevado número de autores, sólo se referencian el que aparece en primer lugar, y los autores pertenecientes a la UAMSomatostatin analogs (SSAs) are recommended for the first-line treatment of most patients with well ...
Carmona Bayonas, Alberto +1 more
core +1 more source
The Tumor Microenvironment in Neuroendocrine Tumors: Biology and Therapeutic Implications
Neuroendocrinology, 2019 Neuroendocrine tumors (NETs) include a heterogeneous group of malignancies arising in the diffuse neuroendocrine system and characterized by indolent growth.
M. Cives +5 more
semanticscholar +1 more source
Clinics, 2011 OBJECTIVE: Description of some of the clinical pathological characteristics of neuroendocrine tumors of the gastroenteropancreatic tract in Brazilian patients.
Bruna Estrozi, Carlos E. Bacchi
doaj +1 more source
Liver transplantation in gastroenteropancreatic neuroendocrine tumors
Frontiers in Oncology, 2023 Neuroendocrine tumors are part of a heterogeneous group of tumors located in organs such as the gastrointestinal tract (GIT), lungs, thymus, thyroid, and adrenal glands. The most prevalent sites are the small intestine, cecal appendix, and pancreas. More
Eduardo de Souza M. Fernandes +24 more
doaj +1 more source